Eagle Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Five
Eagle Pharmaceuticals, Inc. had Lessee, Operating Lease, Liability, to be Paid, Year Five of $0 as of 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive · last filed 2021-11-09
- 2021-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Five $0.00.
- 2021-06-30: Lessee, Operating Lease, Liability, to be Paid, Year Five $0.00.
- 2021-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $0.00.
- 2020-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $413.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Five |
|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 |
| 2020-12-31 | $413.00K 10-K · filed 2021-03-05 |
| 2020-09-30 | $413.00K 10-Q · filed 2020-11-02 |
| 2020-06-30 | $413.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $820.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $820.00K 10-Q · filed 2020-11-02 |
| 2019-09-30 | $1.29M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $485.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $485.00K 10-Q · filed 2019-05-07 |